Argenx Se (ARGX) Accounts Payables (2015 - 2025)
Argenx Se (ARGX) posted Accounts Payables of $1.3 billion for Q4 2025, down 99.88% on a QoQ basis from $1016.2 billion in Q2 2025, and up 94.95% year-over-year from $650.0 million in Q4 2024.
Argenx Se (ARGX) Accounts Payables (2015 - 2025) Analysis & Trends
Argenx Se's Accounts Payables history runs 11 years deep, the most recent figure standing at $1.3 billion for Q4 2025.
- Quarterly Accounts Payables rose 94.95% year-over-year to $1.3 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.3 billion (up 94.95% YoY) and the FY2025 annual result came in at $1.3 billion, up 94.95% from the prior year.
- Accounts Payables was $1.3 billion for Q4 2025 at Argenx Se, down from $1016.2 billion in the prior quarter.
- Across five years, Accounts Payables topped out at $1016.2 billion in Q2 2025 and bottomed at $208.8 million in Q4 2021.
- A 5-year average of $102.0 billion and a median of $362.0 million in 2023 frame the typical range for Accounts Payables.
- Annual changes were most pronounced in 2021 — Accounts Payables dropped 21.89% — and 2025, when it jumped 211675.45%.
- Argenx Se's Accounts Payables stood at $208.8 million in 2021, then jumped by 41.57% to $295.7 million in 2022, then surged by 40.02% to $414.0 million in 2023, then soared by 57.0% to $650.0 million in 2024, then jumped by 94.95% to $1.3 billion in 2025.
- Business Quant data shows ARGX's Accounts Payables at $1.3 billion in Q4 2025, $1016.2 billion in Q2 2025, and $650.0 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 5.74 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 10.62 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 8.64 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 423.55 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 489.30 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 1.03 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 80.54 Mn |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn | 126.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.27 Bn |
| Jun 30, 2025 | 1,016.16 Bn |
| Dec 31, 2024 | 649.99 Mn |
| Jun 30, 2024 | 479.83 Mn |
| Dec 31, 2023 | 414.01 Mn |
| Jun 30, 2023 | 309.99 Mn |
| Dec 31, 2022 | 295.68 Mn |
| Jun 30, 2022 | 257.69 Mn |
| Dec 31, 2021 | 208.85 Mn |
| Jun 30, 2021 | 239.44 Mn |
| Dec 31, 2020 | 267.39 Mn |
| Jun 30, 2020 | 140.82 Mn |
| Dec 31, 2019 | 64.67 Mn |
| Jun 30, 2019 | 61.88 Mn |
| Dec 31, 2018 | 27.57 Mn |
| Jun 30, 2018 | 25.73 Mn |
| Dec 31, 2017 | 18.00 Mn |
| Jun 30, 2017 | 14.37 Mn |
| Dec 31, 2016 | 4.73 Mn |
| Dec 31, 2015 | 2.07 Mn |